These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 21415239)
1. Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients. He XX; Tu SM; Lee MH; Yeung SJ Ann Oncol; 2011 Dec; 22(12):2640-2645. PubMed ID: 21415239 [TBL] [Abstract][Full Text] [Related]
2. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer. He X; Esteva FJ; Ensor J; Hortobagyi GN; Lee MH; Yeung SC Ann Oncol; 2012 Jul; 23(7):1771-80. PubMed ID: 22112968 [TBL] [Abstract][Full Text] [Related]
3. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer. Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175 [TBL] [Abstract][Full Text] [Related]
4. Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional database. Taussky D; Preisser F; Karakiewicz PI; Tilki D; Lambert C; Bahary JP; Delouya G; Wistaff R; Laskine M; Nguyen PV; Durand M; Saad F Can J Urol; 2018 Oct; 25(5):9509-9515. PubMed ID: 30281009 [TBL] [Abstract][Full Text] [Related]
5. Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy. Richards KA; Liou JI; Cryns VL; Downs TM; Abel EJ; Jarrard DF J Urol; 2018 Dec; 200(6):1256-1263. PubMed ID: 29940252 [TBL] [Abstract][Full Text] [Related]
6. Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer. Xiao Y; Zhang S; Hou G; Zhang X; Hao X; Zhang J Tumour Biol; 2014 Mar; 35(3):2035-45. PubMed ID: 24096546 [TBL] [Abstract][Full Text] [Related]
7. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer. Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094 [TBL] [Abstract][Full Text] [Related]
8. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Masoudi FA; Inzucchi SE; Wang Y; Havranek EP; Foody JM; Krumholz HM Circulation; 2005 Feb; 111(5):583-90. PubMed ID: 15699279 [TBL] [Abstract][Full Text] [Related]
9. Preexisting diabetes, metformin use and long-term survival in patients with prostate cancer. Linkeviciute-Ulinskiene D; Patasius A; Kincius M; Zabuliene L; Smailyte G Scand J Urol; 2020 Oct; 54(5):401-407. PubMed ID: 32748714 [TBL] [Abstract][Full Text] [Related]
10. Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database. Rascati K; Richards K; Lopez D; Cheng LI; Wilson J Diabetes Obes Metab; 2013 Oct; 15(10):901-5. PubMed ID: 23531154 [TBL] [Abstract][Full Text] [Related]
11. Antidiabetic drugs influence molecular mechanisms in prostate cancer. Pircher A; Zieher M; Eigentler A; Pichler R; Schäfer G; Fritz J; Puhr M; Steiner E; Horninger W; Klocker H; Heidegger I Cancer Biol Ther; 2018; 19(12):1153-1161. PubMed ID: 30067448 [TBL] [Abstract][Full Text] [Related]
12. Tumor features and survival after radical prostatectomy among antidiabetic drug users. Joentausta RM; Kujala PM; Visakorpi T; Tammela TL; Murtola TJ Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):367-373. PubMed ID: 27502739 [TBL] [Abstract][Full Text] [Related]
13. Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2. Lee SH; Yoon SH; Lee HS; Chung MJ; Park JY; Park SW; Song SY; Chung JB; Bang S Dig Liver Dis; 2016 Apr; 48(4):435-40. PubMed ID: 26775128 [TBL] [Abstract][Full Text] [Related]
14. Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort. Kim HJ; Lee S; Chun KH; Jeon JY; Han SJ; Kim DJ; Kim YS; Woo JT; Nam MS; Baik SH; Ahn KJ; Lee KW Medicine (Baltimore); 2018 Feb; 97(8):e0036. PubMed ID: 29465545 [TBL] [Abstract][Full Text] [Related]
15. Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records. Zghebi SS; Steinke DT; Rutter MK; Emsley RA; Ashcroft DM Diabetes Obes Metab; 2016 Sep; 18(9):916-24. PubMed ID: 27177784 [TBL] [Abstract][Full Text] [Related]
16. Metformin and survival in diabetic patients with breast cancer. El-Benhawy SA; El-Sheredy HG J Egypt Public Health Assoc; 2014 Dec; 89(3):148-53. PubMed ID: 25534180 [TBL] [Abstract][Full Text] [Related]
17. Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer. Bayraktar S; Hernadez-Aya LF; Lei X; Meric-Bernstam F; Litton JK; Hsu L; Hortobagyi GN; Gonzalez-Angulo AM Cancer; 2012 Mar; 118(5):1202-11. PubMed ID: 21800293 [TBL] [Abstract][Full Text] [Related]
18. Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis. Zhou JB; Tang X; Han M; Yang J; Simó R Metabolism; 2020 Aug; 109():154265. PubMed ID: 32446679 [TBL] [Abstract][Full Text] [Related]
19. The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer. Mayer MJ; Klotz LH; Venkateswaran V J Urol; 2017 Apr; 197(4):1068-1075. PubMed ID: 27984108 [TBL] [Abstract][Full Text] [Related]
20. Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer. Arrieta O; Varela-Santoyo E; Soto-Perez-de-Celis E; Sánchez-Reyes R; De la Torre-Vallejo M; Muñiz-Hernández S; Cardona AF BMC Cancer; 2016 Aug; 16():633. PubMed ID: 27519177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]